Navigation Links
HIV/AIDS Vaccine Trial To Be Initiated Soon

It has been proposed to initiate a HIV/AIDS trial in Kericho, as a collaborative work between Kenya Medical Research Institute (KEMRI) and Walter Reed Foundation// within the next two months.

A large number of immigrants who arrive at Kericho to work in the tea estates provide adequate diversity to conduct the research, the results of which can be applied to a large population. Dr. Davy Koech, Director, KEMRI urged the local community members to participate in the trial on a voluntary basis. He also highlighted the need for increased financial and political support, to achieve the predefined research objectives.

Both KEMRI and the Foundation have been involved in conducting vaccine trials over the past eight years. The Kenya based research foundation seeks solution to medical problems, more specifically the AIDS pandemic, through active research that has been instrumental behind the partnership with Walter Reed Foundation.

The AIDS vaccine is currently being tested for its safety and efficacy on over 200 human volunteers in America and Uganda. Animal studies of the vaccine have already yielded promising results.

The infectious disease infects five million people and claims the lives on nearly three million, every year. Currently, more than 65,000 AIDS/HIV infected individuals are being provided anti-retroviral treatment, facilitated by financial support from the Kenyan Government. The coverage of treatment is however, inadequate.

Issues such as safe sex, abstinence from sex, and condom use are slowly beginning to gain importance in a society that has been too conservative to accept it or even discuss about it.

Epidemics of small pox, polio that haunted the entire world have been successfully managed and other diseases like tuberculosis, measles have been brought under control through successful immunization programmes. The strategies applied to such programmes can be incorporated int o the anti-AIDS movement, to make it effective.


'"/>




Related medicine news :

1. Optimum Timing for HIV/AIDS Prognosis
2. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
3. Testing For HIV/AIDS Compulsory For New Military Recruits
4. HIV/AIDS - May push Back the Tide of Progress in India
5. Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness
6. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
7. Relief for HIV/AIDS patients: ART therapy now available in India
8. Conditions Of The HIV/AIDS Patients In The Mizo Society
9. Liberia in safe hands with respect to HIV/AIDS
10. Men queue up for Circumcision In Swaziland To Prevent HIV/AIDS
11. HIV/AIDS Throws Family Relationships Out Of Gear In Uganda
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... Pass, OR (PRWEB) , ... April 29, 2016 , ... ... suggest dinner as the meal to miss. That was among the many new lifestyle ... Nutrition, on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and ...
(Date:4/29/2016)... ... , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. Mickey ... -- are proud of the recent release of their 2014 in vitro fertilization success ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows HRC/OC ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... adding BC and AD, saying it is time to set the record straight. Traditionally, ... says this simply cannot possibly be true and offers explanation. , “To start with, ...
(Date:4/28/2016)... ... April 29, 2016 , ... Sublime Beauty® is offering a special deal on its webstore. ... off. The discount is applied to the product with lesser value. In addition, a ... purchase $250 or more in products. , "So many women (men, too) love our products ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Oasmia Pharmaceutical ... of a new generation of drugs within human ... results for Paclical/Apealea in the Phase III study ... epithelial ovarian cancer. These preliminary results showed non-inferiority ... with carboplatin versus Taxol in combination with carboplatin. ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... 2016 US demand for infection prevention ... percent annually to $27.6 billion in 2020.  Increasing ... decrease rates of healthcare-associated infections (HAIs) will boost ... services.  Although declining, the overall rate of certain ... set by the CDC.  Recent statistics indicate that ...
Breaking Medicine Technology: